Double-blind Control Group Experimental Design
Double-blind Randomized Experiment with Control Group · Also known as: double-blind controlled experiment, DB-CG design, double-masked controlled trial, double-blind controlled study
A double-blind control group experimental design is a rigorous experimental structure in which participants are randomly assigned to at least one treatment group and one control group, while both the participants and the researchers collecting or assessing outcomes are kept unaware of group assignment. By combining allocation concealment with blinding at two levels, the design minimizes expectancy bias, placebo effects, and assessor bias simultaneously, making it a cornerstone of high-quality intervention research in medicine, psychology, and the social sciences.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Use a double-blind control group design when the goal is to establish whether an intervention causes an outcome, and when expectancy effects or assessor bias could plausibly distort results — typical in drug trials, psychotherapy outcome studies, educational interventions with objectively scored outcomes, and consumer product testing. The design requires a clearly defined treatment and control condition that can be rendered indistinguishable to participants and assessors. Do not use it when: blinding is physically impossible (e.g., surgical technique comparisons where the surgeon must know what they are doing); the intervention is inherently transparent (open-label behavioral training); sample sizes are too small to power the study adequately; or the research question is exploratory rather than confirmatory.
Strengths & limitations
- Simultaneously controls for placebo effects, expectancy bias, and assessor bias — providing the strongest evidence for causal inference short of a fully automated trial.
- Random allocation to control group balances confounders, including those unmeasured, across conditions.
- Widely accepted by journals, regulatory agencies, and systematic reviewers as the gold standard for intervention efficacy evidence.
- Enables clean estimation of the treatment effect net of regression to the mean and natural history of the outcome.
- Blinding is difficult or impossible to maintain for behavioral, surgical, or lifestyle interventions where the nature of treatment is inherently apparent.
- Requires substantially larger samples than unblinded designs to achieve equivalent statistical power when blinding is imperfect.
- High internal validity does not guarantee external validity — tightly controlled trial conditions may not reflect real-world practice.
- Ethical constraints may preclude withholding an effective treatment from the control group when efficacy is already partially established.
Frequently asked
What exactly is being 'blinded' in a double-blind design?
Two parties are blinded: (1) participants do not know whether they received the active intervention or the control condition, preventing placebo effects and demand characteristics; and (2) the researchers or clinicians who measure outcomes do not know participants' group assignment, preventing biased assessment. In some trials a third party — the analyst — is also blinded until the statistical analysis plan is locked.
How is this different from a single-blind control group design?
In a single-blind design only one party is blinded — usually the participant. The outcome assessor (researcher, clinician) knows group allocation. This controls placebo effects but leaves assessor bias uncorrected, which matters most when outcome measures involve human judgment. Double-blinding adds assessor masking, closing that gap.
Can I use a double-blind design in behavioral or educational research?
Full double-blinding is rare in behavioral research because the intervention itself is transparent (e.g., a therapy session). However, partial blinding is feasible: participants may be unaware of which 'program version' they received, and outcome raters (who score tests or interviews) can be kept blind to group assignment. Clearly reporting what was and was not blinded is essential.
What sample size do I need?
There is no universal answer — sample size depends on the expected effect size, desired statistical power (conventionally 0.80 or 0.90), alpha level, and outcome variance. Conduct a power analysis before data collection using software such as G*Power. As a rough orientation, detecting a medium effect (Cohen's d = 0.5) with 80% power at alpha = .05 requires approximately 64 participants per group.
What is the control group receiving, and does it matter?
It matters greatly. A no-treatment control inflates the apparent treatment effect by including the placebo response. A placebo control isolates the specific pharmacological or procedural effect. An active comparator control tests whether the new treatment outperforms an already-established one. Choose the control condition based on the scientific question and ethical constraints, then report it transparently.
Sources
How to cite this page
ScholarGate. (2026, June 3). Double-blind Randomized Experiment with Control Group. ScholarGate. https://scholargate.app/en/experimental-design/double-blind-control-group-experimental-design
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Control Group Experimental DesignExperimental design↔ compare
- Factorial ExperimentExperimental design↔ compare
- Pretest-Posttest Experimental DesignExperimental design↔ compare
- Randomized Controlled TrialExperimental design↔ compare
- Single-blind control group experimental designExperimental design↔ compare